CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Trastuzumab
Related studies linked through entity extraction aliases.
T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors
- Status
- COMPLETED
- Phase
- NA
VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Vinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients
- Status
- COMPLETED
- Phase
- PHASE2
Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
- Status
- UNKNOWN
- Phase
- PHASE2
Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women With Stage IV Breast Cancer
- Status
- UNKNOWN
- Phase
- NA
BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Larotaxel in Combination With Weekly Herceptin® in Patients With HER2 Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2